Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Feb;5(2):e40.
doi: 10.1371/journal.pmed.0050040.

Solving the mystery of myelodysplasia

Jerald Radich  1
Affiliations
Review

Solving the mystery of myelodysplasia

Jerald Radich. PLoS Med. 2008 Feb.

Abstract

The author reviews key research on the biology underlying treatment response in myelodysplasia, including a new study inPLoS Medicine.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The author has declared that no competing interests exist.

Figures

Figure 1
Figure 1. The Percentage of Cases of MDS and AML Harboring Specific Classes of Genetic Mutations
See this image and copyright information in PMC

Comment on

References

    1. Heaney ML, Golde DW. Myelodysplasia. New Engl J Med. 1999;340:1649–1660. - PubMed
    1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol. 1982;51:189–199. - PubMed
    1. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100:2292–2302. - PubMed
    1. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–2088. - PubMed
    1. Pedersen-Bjergaard J, Andersen MT, Andersen MK. Genetic pathways in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia. Hematology Am Soc Hematol Educ Program. 2007;2007:392–397. - PubMed